EAM Investors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-9,906
Closed -$1.05M 293
2019
Q1
$1.05M Sell
9,906
-5,811
-37% -$584K 0.26% 182
2018
Q4
$1.31M Sell
15,717
-19,395
-55% -$1.76M 0.36% 132
2018
Q3
$3.58M Buy
+35,112
New +$3.39M 0.53% 51
2018
Q2
Sell
-34,140
Closed -$2.52M 332
2018
Q1
$2.52M Buy
34,140
+2,676
+9% +$200K 0.42% 123
2017
Q4
$2.22M Buy
+31,464
New +$2.27M 0.4% 116

Other funds holding NGVT

EAM Investors's NGVT Position: Q2 2019 in Review

EAM Investors sold out of Ingevity (NGVT) in Q2 2019, closing a stake of 9,906 shares — an estimated $1.05M sold.

EAM Investors first reported a position in NGVT in Q4 2017 and held it in 5 quarters. The position peaked at $3.58M in Q3 2018. 334 funds tracked by Wall St. Rank hold NGVT as of Q2 2019.

  • EAM Investors reported no remaining Ingevity position as of Q2 2019 after selling out during the quarter.
  • EAM Investors sold 9,906 Ingevity shares in Q2 2019, an estimated $1.05M.
  • EAM Investors first reported a position in Ingevity in Q4 2017 and held it in 5 quarters.
  • EAM Investors's Ingevity position peaked at $3.58M in Q3 2018.
  • 334 funds tracked by Wall St. Rank held Ingevity as of Q2 2019.

Based on EAM Investors's 13F filing for Q2 2019, filed 14 Aug 2019.